Tango Therapeutics, Inc. ($TNGX)
Crystal Adam โ President, R&D
Shares
20,251
Price
$15.00
Total Value
$303,765.00
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.31
Transaction Details
| Insider | Crystal Adam |
|---|---|
| Title | President, R&D |
| Transaction Date | Mar 5, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 9, 2026 |
| Shares Sold | 20,251 |
| Price per Share | $15.00 |
| Total Value | $303,765.00 |
| Shares Owned After | 112,622 |
| Derivative | No |
| Accession Number | 0001193125-26-098443 |
| Document | View SEC Filing |